Biot-CRSPR-NH2
Ref. 3D-PP46842
ne
To inquire
Product Information
Name:Biot-CRSPR-NH2
Synonyms:
- Biot-Cys-Arg-Ser-Pro-Arg-amide
Brand:Biosynth
Description:Peptide Biot-CRSPR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Biot-CRSPR-NH2 include the following: Ubiquitination of exposed glycoproteins by SCFFBXO27 directs damaged lysosomes for autophagy Y Yoshida, S Yasuda, T Fujita - Proceedings of the , 2017 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1702615114 Generation of an MC3R knock-out pig by CRSPR/Cas9 combined with somatic cell nuclear transfer (SCNT) technology Y Yin, H Hao, X Xu, L Shen, W Wu , J Zhang - Lipids in health and , 2019 - Springerhttps://link.springer.com/article/10.1186/s12944-019-1073-9 Key considerations in designing CRISPR/Cas9-carrying nanoparticles for therapeutic genome editing Y Xu , R Liu, Z Dai - Nanoscale, 2020 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2020/nr/d0nr05452f Generation of FLAG-tagged Arx knock-in mouse model Y Lim, IT Cho, JA Golden, G Cho - 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/dvg.23479 Integrin alphaIIbbeta3 and platelet function X Du , MH Ginsberg - Thrombosis and haemostasis, 1997 - thieme-connect.comhttps://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0038-1657508 Generating a New sgRNA Vector, pGL3-U6-sgRNA-PGK-mRFP-T2A-PuroR, to Improve Base Editing TE Ayo , H Xu - Journal of genome editing and regulation, 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698695/ Optimization of rice panicle architecture by specifically suppressing ligand-receptor pairs T Guo, ZQ Lu, Y Xiong, JX Shan, WW Ye - Nature , 2023 - nature.comhttps://www.nature.com/articles/s41467-023-37326-x Exploiting Crispr-Cas System to Combat Antibiotic Resistance: A Review T Geinoro, G Chala, W Mulugeta - 2024 - researchgate.nethttps://www.researchgate.net/profile/Tariku-Geinoro/publication/379153760_Exploiting_Crispr-Cas_System_to_Combat_Antibiotic_Resistance_A_Review/links/65fd2feca8baf573a1cbf4bb/Exploiting-Crispr-Cas-System-to-Combat-Antibiotic-Resistance-A-Review.pdf Carnosine dipeptidase II (CNDP2) protects cells under cysteine insufficiency by hydrolyzing glutathione-related peptides S Kobayashi , T Homma, N Okumura, J Han - Free Radical Biology , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0891584921004366 A new antigen SUMI carried on glycophorin A encoded by the GYPA*M with c.91A>C (p.Thr31Pro) belongs to the MNS blood group system S Ito, S Kaito, T Miyazaki, G Kikuchi, K Isa - , 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/trf.15828 Tissue-specific disruption of the growth hormone receptor (GHR) in mice: An update S Duran-Ortiz , V Noboa, JJ Kopchick - Growth Hormone & IGF Research, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1096637419300619 CRISPR/Cas9-mediated knock-in of alligator cathelicidin gene in a non-coding region of channel catfish genome RMC Simora , D Xing , MR Bangs , W Wang , X Ma - Scientific reports, 2020 - nature.comhttps://www.nature.com/articles/s41598-020-79409-5 When the guardian sleeps: Reactivation of the p53 pathway in cancer O Merkel, N Taylor, N Prutsch, PB Staber - Research/Reviews in , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1383574216301223 Targeted mutagenesis in plants using Beet curly top virus for efficient delivery of CRISPR/Cas12a components O Eini , N Schumann, M Niessen, M Varrelmann - New Biotechnology, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1871678421000984 Chaski, a novel Drosophila lactate/pyruvate transporter required in glia cells for survival under nutritional stress MG Delgado , C Oliva , E Lopez , A Ibacache, A Galaz - Scientific reports, 2018 - nature.comhttps://www.nature.com/articles/s41598-018-19595-5 Genome Editing of Golden SNP-Carrying Lycopene Epsilon-Cyclase (LcyE) Gene Using the CRSPR-Cas9/HDR and Geminiviral Replicon System in Rice JH Kim, J Yu, HK Kim, JY Kim, MS Kim, YG Cho - International Journal of , 2022 - mdpi.comhttps://www.mdpi.com/1422-0067/23/18/10383 200 Evaluating novel peptide therapeutics targeting pathogenic macrophages in systemic sclerosis J Stanway, BA Abdi, H Lopez, G Martin - Rheumatology, 2018 - academic.oup.comhttps://academic.oup.com/rheumatology/article-pdf/doi/10.1093/rheumatology/key075.424/24768323/key075.424.pdf Metal-tagged CRISPR/Cas12a bioassay enables ultrasensitive and highly selective evaluation of kanamycin bioaccumulation in fish samples J Hu, H Song, J Zhou, R Liu, Y Lv - Analytical Chemistry, 2021 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.1c03094 Targeting Nanoparticle Probes to Differentiating Stem Cells J Cabral-Teixeira, K Talsky, L Zhang , J Maurer - researchgate.nethttps://www.researchgate.net/profile/Dana-Larocca/publication/287054473_Targeting_nanoparticle_probes_to_differentiating_stem_cells/links/5702fe9a08ae646a9da87d31/Targeting-nanoparticle-probes-to-differentiating-stem-cells.pdf 198 Critical role of the prolyl 3-hydroxylase LEPREL1 in scleroderma-related fibrosis BA Ahmed, X Shiwen, C Denton, G Martin - , 2018 - academic.oup.comhttps://academic.oup.com/rheumatology/article-pdf/doi/10.1093/rheumatology/key075.422/24768319/key075.422.pdf CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases A Karimian , N Gorjizadeh, F Alemi , Z Asemi, K Azizian - Life Sciences, 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0024320520309176
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Technical inquiry about: Biot-CRSPR-NH2
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.